Navigation Links
Sex Hormones Don't Seem to Affect Prostate Cancer Risk
Date:1/29/2008

Finding could spur research into other causes of the disease

TUESDAY, Jan. 29 (HealthDay News) -- A man's risk of prostate cancer is not related to the amount of sex hormones circulating in his bloodstream, a new British analysis suggests.

The conclusion was based on a review of 18 studies -- representing 95 percent of all available research -- that looked into potential links between the disease and blood hormone levels, the study authors said.

"There has been a long interest in whether or not natural variations in hormone levels in a man's blood are related to future disease risk," said study author Andrew Roddam, of the Cancer Research UK Epidemiology Unit at the University of Oxford. "What we have shown in this collaboration is that these natural fluctuations in levels of androgens [and estrogens] do not appear to be related to subsequent risk [for] the disease."

The findings were published online in the Jan. 29 issue of the Journal of the National Cancer Institute.

Prostate cancer is the most common type of cancer in American men, other than skin cancer. An estimated 220,000 new cases of prostate cancer were diagnosed in the United States in 2007, and about 27,000 men died from the disease, according to the American Cancer Society.

Although there's no single known cause of prostate cancer, risk is higher for those over the age of 50, black men, and those with a family history of the disease.

High levels of male sex hormones, known as androgens, have long been believed to be a risk factor for prostate cancer. To explore a possible hormone-cancer risk connection, Roddam and his colleagues analyzed data from studies that involved more than 10,000 men with and without prostate cancer. The research had been conducted between 1961 and 2001, and most study participants with prostate cancer had been diagnosed after the age of 60.

After compensating for other factors -- such as age, body-mass index, marital and educational status, smoking history and alcohol consumption -- the study authors found no statistical correlation between pre-diagnosis sex hormone concentrations in the bloodstream and the risk for developing prostate cancer.

Similarly, no hormone level combination -- such as a very high concentration of one sex hormone and a very low concentration of another -- was associated with prostate cancer risk.

In an accompanying editorial, co-author Dr. Paul A. Godley, an associate professor of medicine at the University of North Carolina School of Medicine, said the "impressive" findings could push prostate cancer research in a new direction.

"Researchers should redirect their attention toward investigations of potentially modifiable nutritional, lifestyle or environmental risk factors," he suggested, rather than target unchangeable factors -- such as blood hormone levels -- that do not appear to affect risk.

But, Dr. Peter T. Scardino, chairman of the department of surgery at Memorial Sloan-Kettering Cancer Center in New York City, cautioned that it would be wrong to conclude that male hormones have nothing to do with prostate cancer.

"This study asks if the amount of male or female hormones in your bloodstream can predict whether you will get prostate cancer, and the answer is no," he said. "But the prostate is like a sponge for hormones that sucks them out of circulation and converts them to even more powerful forms that can go to work in the prostate. So blood hormone levels may not have any connection with the amount of hormone in the prostate gland itself.

"The point is," he added, "I would not want people to think that altering the male hormone environment in the prostate has no effect. It certainly will. So if you take drugs like finestaride to shrink your prostate to urinate better, or Propecia to prevent balding, these drugs are working directly on hormone levels in the prostate, not the bloodstream. And these drugs work very well."

More information

For additional information on prostate cancer risk, visit the American Cancer Society.



SOURCES: Andrew Roddam, Ph.D., Cancer Research UK Epidemiology Unit, University of Oxford, Great Britain; Paul A. Godley, M.D., Ph.D., departments of epidemiology and medicine, University of North Carolina School of Medicine, Chapel Hill; Peter T. Scardino, M.D., chairman, department of surgery, Memorial Sloan-Kettering Cancer Center, New York City; Jan. 29, 2008, Journal of the National Cancer Institute, online


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Reduce Stress Hormones to Beat Sleep Problems
2. Experts call for better research into link between womens hormones and mood disorders
3. FDA Asserts New Policy to Restrict Womens Access to Bioidentical Hormones
4. Growing Link Between Diabetes and Periodontal Disease Focus of National Gathering for Health Care Leaders
5. Treating your periodontal pockets may benefit your pocket book
6. Ortho Organizers(R) Announces the Launch of the Ancor Pro(TM) Orthodontic Anchorage System Hands-on Course
7. Survey confirms Americans prefer root canal treatment by endodontists
8. Cutting Salt Wont Affect Foods Safety
9. A childs IQ could be affected by maternal epilepsy
10. Sexual function affected by stem cell transplant according to long-term study
11. Family history of alcoholism affects response to drug used to treat heavy drinking
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... 17, 2017 , ... Peoples Health is pleased to announce ... Dec. 1, 2016. Peoples Health, a Metairie-based Medicare Advantage company, serves more than ... to our provider network, and the addition will benefit our members in the ...
(Date:1/17/2017)... ... January 17, 2017 , ... A prescription medication bottle, pocket knife, luggage and ... to Cradle Product Design Challenge , the Cradle to Cradle Products Innovation Institute ... design challenges scheduled to run through early 2018. The challenges are presented by the ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... Neil H. ... financial planning assistance to communities throughout the region, is launching a charity drive to ... disease is by far the deadliest killer in America, and is responsible for 1 ...
(Date:1/17/2017)... ... January 17, 2017 , ... SC&H Group, a leading ... a Principal in its IT Advisory Services practice . Rossi is the third ... market demand for strategic IT guidance grows, and the practice continues to expand.     , ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... and eliminate cyber threats in real-time, today announced a strategic partnership with ... Selangor, Malaysia. Joining other Seceon partners, TechLab Security has become a strategic partner ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... -- Edwards Lifesciences Corporation (NYSE: EW ), the ... and critical care monitoring, plans to announce its operating ... the market closes on Wednesday, February 1, 2017, and ... that day to discuss those results. To ... (201) 689-8037.  For 72 hours following the call, an ...
(Date:1/17/2017)... PUNE, India , Jan. 17, 2017  Market Research Future ... Global Endoscopy Devices Market is expected to reach USD 33.6 million ... 2016. Market Highlights ... The Global Endoscopy Devices Market has been examined as ... rate. Globally there is huge demand for endoscopy device in various ...
(Date:1/17/2017)... Research and Markets has announced the addition of the ... offering. ... global fluoropolymer market in the healthcare industry to grow at a ... Fluoropolymer Market in the Healthcare Industry 2016-2020, has been prepared based ... report covers the market landscape and its growth prospects over the ...
Breaking Medicine Technology: